Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,363,324
-$132,029,719 QoQ
Shares Held
812,181
-49.6% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#84
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 71%
None 29%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$3,041,025
PutShares
19,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in ZTS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,363,324 | 812,181 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $190,393,043 | 1,610,634 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $243,704,655 | 1,936,931 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $481,807,760 | 3,292,836 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,041,025 | 19,500 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $498,960,931 | 3,199,493 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $556,053,342 | 3,377,184 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $523,942,633 | 3,215,753 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $597,153,762 | 3,056,371 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $537,309,034 | 3,099,383 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $714,675,858 | 4,223,603 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $587,390,878 | 2,976,090 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $537,792,533 | 3,091,117 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $557,806,786 | 3,239,108 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $472,712,730 | 2,840,139 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $269,486,542 | 1,838,871 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $222,456,795 | 1,500,147 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $190,856,509 | 1,110,341 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $177,464,130 | 941,005 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $434,146,937 | 1,779,072 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $333,697,342 | 1,718,849 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $165,955,255 | 890,509 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $115,531,420 | 733,626 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $99,603,692 | 601,835 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $116,455,867 | 704,214 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $117,136,581 | 854,762 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $91,743,942 | 779,539 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||